Sun X J, Wang F Z, Zheng H, Miao N, Wang H Q, Yin Z D, Zhang G M
National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing 100050, China.
Zhonghua Liu Xing Bing Xue Za Zhi. 2018 Oct 10;39(10):1351-1355. doi: 10.3760/cma.j.issn.0254-6450.2018.10.012.
Through analyzing the epidemiological characteristics of hepatitis A and E and the situation of vaccination, to promote the recommendation profile on Hepatitis E vaccination program, in China. Three phases of time span were divided as 2004-2007, 2008-2011 and 2012-2015, with age groups divided as <20, 20-29, 30-39 and ≥40. Incidence rates in both different phases and age groups were compared. Numbers of Hepatitis A and E vaccines released and used, were described. Between 2004 and 2015, a declining trend in the reported incidence of hepatitis A (=-12.15, <0.001), but an increasing trend in hepatitis E (=6.63, <0.001) were noticed. The mean number of hepatitis A cases declined from 6 515 to 1 986 between 2004 and 2007 while the number of hepatitis E cases increased from 1 491 to 2 277 between 2012 and 2015. The peaks of hepatitis E appeared persistent annually, in March. The incidence of hepatitis A declined in three regions, with the western region (3.46/100 000) much higher than the eastern (1.13/100 000) or central regions (1.14/100 000) ((2)=32 630, <0.01). The incidence of hepatitis E increased both in the central (1.74/100 000) and western regions (1.58/100 000), but more in the eastern region (2.66/100 000) ((2)=6 009, <0.01). Incidence of hepatitis A declined in all age groups and declined by 84.36% among the 0-19 group. However, the incidence of hepatitis E showed an increasing trend among the ≥20 group. Incidence rates appeared higher in the older age groups. The coverage of hepatitis A vaccine increased from 62.05% to 93.54%, but with a negative association seen between the coverage of Hepatitis A vaccine and the incidence (=10.69, (2)<0.05). The incidence of Hepatitis A declined sharply in China while hepatitis E was still increasing from 2004 to 2015, calling for the expansion on the coverage of Hepatitis E vaccine in the whole population.
通过分析甲型和戊型肝炎的流行病学特征及疫苗接种情况,以推动中国戊型肝炎疫苗接种计划的推荐方案。将时间跨度分为三个阶段,即2004 - 2007年、2008 - 2011年和2012 - 2015年,年龄组分为<20岁、20 - 29岁、30 - 39岁和≥40岁。比较不同阶段和年龄组的发病率。描述甲型和戊型肝炎疫苗的发放和使用数量。2004年至2015年期间,甲型肝炎报告发病率呈下降趋势(=-12.15,<0.001),而戊型肝炎呈上升趋势(=6.63,<0.001)。2004年至2007年期间,甲型肝炎病例平均数从6515例降至1986例,而2012年至2015年期间,戊型肝炎病例数从1491例增至2277例。戊型肝炎的发病高峰每年3月持续出现。甲型肝炎发病率在三个地区均下降,西部地区(3.46/10万)远高于东部地区(1.13/10万)或中部地区(1.14/10万)((2)=32630,<0.01)。戊型肝炎发病率在中部地区(1.74/10万)和西部地区(1.58/10万)均上升,但东部地区上升幅度更大(2.66/10万)((2)=6009,<0.01)。所有年龄组的甲型肝炎发病率均下降,0 - 19岁年龄组下降了84.36%。然而,≥20岁年龄组的戊型肝炎发病率呈上升趋势。发病率在年龄较大的年龄组中似乎更高。甲型肝炎疫苗接种率从62.05%提高到93.54%,但甲型肝炎疫苗接种率与发病率呈负相关(=10.69,(2)<0.05)。2004年至2015年期间,中国甲型肝炎发病率急剧下降,而戊型肝炎仍在上升,因此需要扩大戊型肝炎疫苗在全人群中的接种率。